Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Report

Global and Region Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：170
  • REPORT CODE：GMM923654
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike.

    Increasing demand for combination therapies therapy is expected to fuel the future growth of the ITP therapeutics market. Clinical evidence suggest that combination therapies entail relatively lower side effects, are cost effective and display higher response rates in patients.

    The report details the trend, potential and market size of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Idiopathic Thrombocytopenic Purpura (ITP) Therapeuticsmarket, defines the market attractiveness level of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics industry, describes the types of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market and the development prospects and opportunities of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market in Chapter 13.

    By Player:

    • Grifols Biologicals Inc

    • Amgen Inc

    • GlaxoSmithKline Plc

    • Roch

    By Type:

    • Corticosteroids

    • Intravenous Immunoglobulin (IVIG)

    • Anti-D Immunoglobulin

    • Thrombopoietin Receptor Agonists (TPO-RA)

    • Others

    By End-User:

    • Hospitals

    • Clincs

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.2 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.4 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.6 India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast (2022-2028)

    9 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Corticosteroids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intravenous Immunoglobulin (IVIG) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Anti-D Immunoglobulin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Thrombopoietin Receptor Agonists (TPO-RA) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clincs Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Intravenous Immunoglobulin (IVIG) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Anti-D Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Thrombopoietin Receptor Agonists (TPO-RA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clincs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Competitive Analysis

    • 14.1 Grifols Biologicals Inc

      • 14.1.1 Grifols Biologicals Inc Company Details

      • 14.1.2 Grifols Biologicals Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Grifols Biologicals Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • 14.2 Amgen Inc

      • 14.2.1 Amgen Inc Company Details

      • 14.2.2 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • 14.3 GlaxoSmithKline Plc

      • 14.3.1 GlaxoSmithKline Plc Company Details

      • 14.3.2 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • 14.4 Roch

      • 14.4.1 Roch Company Details

      • 14.4.2 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics

    • Figure Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Picture

    • Table Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Immunoglobulin (IVIG) Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-D Immunoglobulin Consumption and Growth Rate (2017-2022)

    • Figure Global Thrombopoietin Receptor Agonists (TPO-RA) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clincs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Immunoglobulin (IVIG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-D Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thrombopoietin Receptor Agonists (TPO-RA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clincs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Grifols Biologicals Inc (Foundation Year, Company Profile and etc.)

    • Table Grifols Biologicals Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Biologicals Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service

    • Table Roch (Foundation Year, Company Profile and etc.)

    • Table Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US